HK1044169A1 - Vascular adhesion molecules and modulation of their function - Google Patents

Vascular adhesion molecules and modulation of their function

Info

Publication number
HK1044169A1
HK1044169A1 HK02104558.4A HK02104558A HK1044169A1 HK 1044169 A1 HK1044169 A1 HK 1044169A1 HK 02104558 A HK02104558 A HK 02104558A HK 1044169 A1 HK1044169 A1 HK 1044169A1
Authority
HK
Hong Kong
Prior art keywords
adhesion molecules
modulation
function
vascular adhesion
cram
Prior art date
Application number
HK02104558.4A
Other languages
English (en)
Inventor
Beat Albert Imhof
Michel Aurrand-Lions
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of HK1044169A1 publication Critical patent/HK1044169A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
HK02104558.4A 1999-03-11 2002-06-19 Vascular adhesion molecules and modulation of their function HK1044169A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99200746 1999-03-11
PCT/EP2000/002219 WO2000053749A2 (en) 1999-03-11 2000-03-13 Vascular adhesion molecules and modulation of their function

Publications (1)

Publication Number Publication Date
HK1044169A1 true HK1044169A1 (en) 2002-10-11

Family

ID=8239973

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104558.4A HK1044169A1 (en) 1999-03-11 2002-06-19 Vascular adhesion molecules and modulation of their function

Country Status (23)

Country Link
US (3) US7393651B2 (xx)
EP (2) EP2292761A1 (xx)
JP (2) JP4836329B2 (xx)
CN (2) CN100469878C (xx)
AT (1) ATE500328T1 (xx)
AU (1) AU782139B2 (xx)
BR (1) BR0008915A (xx)
CA (1) CA2362896C (xx)
CZ (1) CZ303128B6 (xx)
DE (1) DE60045681D1 (xx)
EE (1) EE05497B1 (xx)
ES (1) ES2361905T3 (xx)
HK (1) HK1044169A1 (xx)
HU (1) HU229376B1 (xx)
IL (1) IL145310A0 (xx)
IS (1) IS2819B (xx)
MX (1) MXPA01009110A (xx)
NO (1) NO333085B1 (xx)
NZ (1) NZ514091A (xx)
PL (1) PL207994B1 (xx)
RU (1) RU2244748C2 (xx)
WO (1) WO2000053749A2 (xx)
ZA (1) ZA200107283B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
NZ514091A (en) * 1999-03-11 2004-01-30 Rmf Dictagene S Vascular adhesion molecules and modulation of their function
GB0100750D0 (en) * 2001-01-11 2001-02-21 Inpharmatica Ltd Novel proteins
WO2003006673A2 (en) * 2001-07-11 2003-01-23 Texas Biotechnology Corporation A nucleic acid encoding a human junctional adhesion protein (jam3)
EP1533617A1 (en) * 2003-11-19 2005-05-25 RMF Dictagene S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
US7642341B2 (en) 2003-12-18 2010-01-05 Merck Serono S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer
CA2624393C (en) 2005-11-04 2016-01-05 Genentech, Inc. Use of complement pathway inhibitors to treat ocular diseases
RU2464030C2 (ru) * 2006-05-26 2012-10-20 Регадо Байосайенсиз, Инк. Введение противосвертывающей системы reg1
US8007797B2 (en) 2006-09-28 2011-08-30 Merck Serono S.A. Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use
PL2907827T3 (pl) 2006-11-02 2019-03-29 Genentech, Inc. Humanizowane przeciwciała przeciw czynnikowi D i ich zastosowanie
FR2909092B1 (fr) * 2006-11-24 2012-10-19 Pf Medicament Nouveaux anticorps anti-proliferation
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
PT2190991T (pt) * 2007-08-06 2019-12-16 Noxxon Pharma Ag Ácidos nucleicos que se ligam a sdf 1 e a sua utilização
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
US10093978B2 (en) 2013-08-12 2018-10-09 Genentech, Inc. Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms
CR20160561A (es) 2014-05-01 2017-05-03 Genentech Inc Variantes del anticuerpo anti-factor d y sus usos
US10654932B2 (en) 2015-10-30 2020-05-19 Genentech, Inc. Anti-factor D antibody variant conjugates and uses thereof
US10407510B2 (en) 2015-10-30 2019-09-10 Genentech, Inc. Anti-factor D antibodies and conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053753A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
US20030170864A1 (en) * 2000-05-30 2003-09-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
SE9604470D0 (sv) * 1996-12-04 1996-12-04 Tamas Bartfai Konsulting Ab Transmembrane component of tight junction
EP0973892A2 (en) * 1997-03-14 2000-01-26 Human Genome Sciences, Inc. 28 human secreted proteins
AU6578398A (en) * 1997-03-21 1998-10-20 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
ATE361933T1 (de) 1997-08-01 2007-06-15 Serono Genetics Inst Sa 5' ests für sekretierte proteine aus gehirngeweben
US20030049676A1 (en) * 1997-09-17 2003-03-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1002864A1 (en) * 1998-11-10 2000-05-24 Universita' degli studi di Bologna HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections
IL142794A0 (en) * 1998-12-16 2002-03-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
NZ514091A (en) * 1999-03-11 2004-01-30 Rmf Dictagene S Vascular adhesion molecules and modulation of their function
EP1533617A1 (en) * 2003-11-19 2005-05-25 RMF Dictagene S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
US7642341B2 (en) * 2003-12-18 2010-01-05 Merck Serono S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer

Also Published As

Publication number Publication date
CN1355843A (zh) 2002-06-26
RU2244748C2 (ru) 2005-01-20
US7393651B2 (en) 2008-07-01
ZA200107283B (en) 2002-12-24
AU4105100A (en) 2000-09-28
CZ20013267A3 (cs) 2002-02-13
JP4836329B2 (ja) 2011-12-14
IS2819B (is) 2012-12-15
NZ514091A (en) 2004-01-30
PL350417A1 (en) 2002-12-16
NO20014417D0 (no) 2001-09-11
JP2002537837A (ja) 2002-11-12
US20100267649A1 (en) 2010-10-21
WO2000053749A2 (en) 2000-09-14
IL145310A0 (en) 2003-01-12
MXPA01009110A (es) 2002-08-20
NO333085B1 (no) 2013-02-25
CZ303128B6 (cs) 2012-04-18
BR0008915A (pt) 2002-04-09
EE200100472A (et) 2002-12-16
ATE500328T1 (de) 2011-03-15
CN1637019A (zh) 2005-07-13
IS6072A (is) 2001-09-10
ES2361905T3 (es) 2011-06-24
CN100469878C (zh) 2009-03-18
EP2292761A1 (en) 2011-03-09
JP2010233572A (ja) 2010-10-21
DE60045681D1 (de) 2011-04-14
US20050266426A1 (en) 2005-12-01
US8143056B2 (en) 2012-03-27
EE05497B1 (et) 2011-12-15
AU782139B2 (en) 2005-07-07
HUP0200606A2 (en) 2002-06-29
CA2362896A1 (en) 2000-09-14
EP1163337A2 (en) 2001-12-19
CA2362896C (en) 2012-07-31
HUP0200606A3 (en) 2004-11-29
EP1163337B1 (en) 2011-03-02
US20080274970A1 (en) 2008-11-06
US7670826B2 (en) 2010-03-02
HU229376B1 (en) 2013-11-28
WO2000053749A3 (en) 2000-12-14
PL207994B1 (pl) 2011-02-28
NO20014417L (no) 2001-11-12

Similar Documents

Publication Publication Date Title
ZA200107283B (en) Vascular adhesion molecules and modulation of their function.
PT1132403E (pt) Peptidos inibidores de tgf g beta1
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
DE69427650T2 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
DK0770089T3 (da) Vækstdifferentieringsfaktor-12
BR9007115A (pt) Novo trombolitico
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
DK1431391T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
EP0870036A4 (en) MAMMALIAN SYNTHETIC ALPHA-N-ACETYLGLUCOSAMINIDASE AND GENE SEQUENCES ENCODING IT
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
BG105682A (en) Bone stimulating factor
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
EP0832109A4 (en) FIBROPLAST GROWTH FACTOR APPROVED FACTOR-2 AND METHODS OF USE
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
WO1999046381A3 (en) Human fgf gene and gene expression products
DE500713T1 (de) Derivate des 3,3,5-trimethylcyclohexylesters von 2-methylpropionsaeure, ihr herstellungsverfahren sowie diese enthaltende therapeutische kompositionen.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180313